"Coronary Restenosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Recurrent narrowing or constriction of a coronary artery following surgical procedures performed to alleviate a prior obstruction.
| Descriptor ID |
D023903
|
| MeSH Number(s) |
C14.280.647.250.285.200 C14.907.585.250.285.200
|
| Concept/Terms |
Coronary Restenosis- Coronary Restenosis
- Coronary Restenoses
- Restenoses, Coronary
- Restenosis, Coronary
|
Below are MeSH descriptors whose meaning is more general than "Coronary Restenosis".
Below are MeSH descriptors whose meaning is more specific than "Coronary Restenosis".
This graph shows the total number of publications written about "Coronary Restenosis" by people in this website by year, and whether "Coronary Restenosis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 2 | 0 | 2 |
| 2004 | 1 | 1 | 2 |
| 2010 | 0 | 1 | 1 |
| 2015 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Coronary Restenosis" by people in Profiles.
-
Implementation of miRNAs to Reduce In-Stent Restenosis in the Future. J Am Coll Cardiol. 2015 Jun 02; 65(21):2328-30.
-
First-in-man study evaluating the safety and efficacy of a second generation biodegradable polymer sirolimus-eluting stent in the treatment of patients with de novo coronary lesions: clinical, Angiographic, and OCT outcomes of CREDIT-1. Catheter Cardiovasc Interv. 2015 Mar; 85 Suppl 1:744-51.
-
Outcomes of unselected recipients of sirolimus-eluting stents: the Cypher stent U.S. post-marketing surveillance registry. J Invasive Cardiol. 2010 Feb; 22(2):48-55.
-
Patterns and outcomes of drug-eluting coronary stent use in clinical practice. Am Heart J. 2006 Aug; 152(2):321-6.
-
On- versus off-label use of drug-eluting coronary stents in clinical practice (report from the American College of Cardiology National Cardiovascular Data Registry [NCDR]). Am J Cardiol. 2006 May 15; 97(10):1478-81.
-
Are drug-eluting stents the preferred treatment for multivessel coronary artery disease? J Am Coll Cardiol. 2006 Jan 03; 47(1):22-6.
-
Drug eluting stents: case study in the acceptance of a new medical technology. Catheter Cardiovasc Interv. 2005 Apr; 64(4):528-30.
-
Coronary complications of percutaneous coronary intervention: a practical approach to the management of abrupt closure. Catheter Cardiovasc Interv. 2005 Mar; 64(3):395-401.
-
Silent myocardial ischemia: concepts and controversies. Am J Med. 2004 Jan 15; 116(2):112-8.
-
Intracoronary beta brachytherapy as a treatment option for high-risk refractory in-stent restenosis; Compassionate use. Cardiovasc Radiat Med. 2004 Jan-Mar; 5(1):9-14.